Supply Chain

Jan 23, 2017
A new report says that failure to account for rebates, discounts, and price concessions leads to an “overstatement of payments realized by manufacturers” in most annual industry drug spend reports.
Jan 10, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
B&W Tek’s director of Market and Customer Development, Katherine A. Bakeev, PhD, discusses analysis of pharmaceutical raw materials and the benefits of using laser-induced breakdown spectroscopy (LIBS).
Jan 03, 2017
TraceLink’s first Drug Supply, Safety and Traceability Report suggests that 19% of pharma companies, 11% of distributors, and 9% of dispensers still haven’t begun to address lot-level serialization requirements. Only 20% say their CMOs will be ready for the November 2017 deadline.
Jan 02, 2017
Pharmaceutical Technology
Moisture uptake during the end-to-end manufacturing process and supply chain can affect product quality. Simulation tools based on mechanistic models help define storage and handling requirements for oral solid-dosage drugs.
Dec 21, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
The two companies have entered into an agreement to provide Suzeken with access to AmerisourceBergen’s Cubixx inventory solution.
Nov 15, 2016
Pharmaceutical Technology
Pressures to accelerate current and next-gen therapies are challenging traditional microbiological testing models.
Nov 15, 2016
Pharmaceutical Technology
Ensuring that materials have optimal critical quality attributes for the required formulations is crucial.
Nov 15, 2016
Pharmaceutical Technology
Could greater market transparency improve pharmaceutical quality and regulatory compliance?
Nov 15, 2016
Pharmaceutical Technology
In InstantGMP, cloud-based IT and an approach grounded in cGMPs, brings more of the power of paperless recordkeeping to manufacturers, at a fraction of the cost.
Nov 15, 2016
Pharmaceutical Technology
PDA’s first aging facilities survey suggests that post-approval changes play a major part in slowing pharmaceutical industry investment in new technology.
native1_300x100
lorem ipsum